Anticancer Studies of Leucovorin against Methotrexate Induced Genotoxicity in Swiss Albino Mice

Author(s): Chandra Sekhar Singh Bhaludra, Adharvana Chari Murugulla, Chakrapani Pullagummi, Ajay kumar Polkampally, Roja Rani Anupalli

Journal Name: Letters in Drug Design & Discovery

Volume 11 , Issue 1 , 2014

Become EABM
Become Reviewer


Leucovorin is one of the several chemically active reduced derivatives of folic acid. It is used as an antidote to folic acid antagonist. Lecovorin calcium inj U.S.P. contains calcium folinate which belongs to a group of vitamins, used as an antidote to the harmful effects of Methotrexate (MTX) therapy. In this investigation, the modulatory effects exerted by the Leucovorin against MTX induced genotoxicity in mice by using Chromosomal Aberrations (CA) and sperm morphology assays were tested. Three different doses of Leucovorin were selected and tested for their modulatory activity on the genotoxicity exerted by 20 mg/kg of MTX. The results of the present study indicate a significant decrease in the frequency of CA and sperm head abnormalities suggesting that the Leucovorin modulates the MTX induced genotoxicity in a dose dependent manner and it reveals its antitoxic nature and suggests using along with chemotherapeutic agents in cancer chemotherapy. These findings provide the future directions for the research on design and development of possible modulatory drugs containing Leucovorin.

Keywords: Leucovorin, Genotoxicity, Chromosomal aberrations, Sperm head abnormalities.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [10 - 14]
Pages: 5
DOI: 10.2174/15701808113109990052

Article Metrics

PDF: 33